These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
215 related items for PubMed ID: 23235757
1. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer. Lee HJ, Kim YS, Shin SS, Nam JH, Kim YT, Han S, Choi EK. Tumori; 2012; 98(5):615-21. PubMed ID: 23235757 [Abstract] [Full Text] [Related]
2. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule. Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer (Vulva Cancer) Committee of Japanese Gynecologic Oncology Group (JGOG). Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110 [Abstract] [Full Text] [Related]
3. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma. Pathy S, Kumar L, Pandey RM, Upadhyay A, Roy S, Dadhwal V, Madan R, Chander S. Asian Pac J Cancer Prev; 2015 Aug; 16(12):5075-9. PubMed ID: 26163644 [Abstract] [Full Text] [Related]
11. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066). Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K, Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group. Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262 [Abstract] [Full Text] [Related]